Cargando…
Immune Response Modifications in the Genetic Forms of Parkinson’s Disease: What Do We Know?
Parkinson’s disease (PD) is a common neurodegenerative disease characterized by loss of dopaminergic neurons in the pars compacta of the midbrain substantia nigra. PD pathophysiology is complex, multifactorial, and not fully understood yet. Nonetheless, recent data show that immune system hyperactiv...
Autores principales: | Magistrelli, Luca, Contaldi, Elena, Vignaroli, Francesca, Gallo, Silvia, Colombatto, Federico, Cantello, Roberto, Comi, Cristoforo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998358/ https://www.ncbi.nlm.nih.gov/pubmed/35408836 http://dx.doi.org/10.3390/ijms23073476 |
Ejemplares similares
-
The Effects of COVID-19-Related Restrictions on Parkinson’s Disease Patients in Italy: Results of a Structured Survey
por: Martini, Stefano, et al.
Publicado: (2022) -
Motor and non-motor symptom improvement after mRNA-1273 vaccine in a Parkinson’s disease patient
por: Contaldi, Elena, et al.
Publicado: (2021) -
T Lymphocytes in Parkinson’s Disease
por: Contaldi, Elena, et al.
Publicado: (2022) -
Striatal dopamine transporter imaging in Parkinson’s disease drug-naïve patients: focus on sexual dysfunction
por: Contaldi, Elena, et al.
Publicado: (2022) -
The Impact of SNCA Variations and Its Product Alpha-Synuclein on Non-Motor Features of Parkinson’s Disease
por: Magistrelli, Luca, et al.
Publicado: (2021)